Skip to main content

Articles

FDA Approvals
Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer with BRCA Mutation
Read More
FDA Approvals
Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker
Read More
FDA Approvals
Carvykti Second BCMA-Directed CAR T-Cell Therapy FDA Approved for Multiple Myeloma
Read More
FDA Approvals
Opdualag, a Novel Immunotherapy Combination, FDA Approved for Advanced Melanoma
Read More
FDA Approvals
Pluvicto FDA Approved for PSMA-Positive Metastatic Prostate Cancer
Read More
Market Access
Interview with the Innovators
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Anthony Mancini, Ron Graybill
Read More
Perspectives
A Hollywood-Style Teachable Moment
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Pain, Multiple Sclerosis
Multiple Sclerosis: Systemic Challenges to Cost-Effective Care
David R. Weinstein, PhD, Gary M. Owens, MD, Ankit Gandhi, PharmD
David R. Weinstein, PhD; Gary M. Owens, MD; Ankit Gandhi, PharmD
Read More
Original Research
Migration of Hospital Total Hip and Knee Arthroplasty Procedures to an Ambulatory Surgery Center Setting and Postsurgical Opioid Use: A Private Practice Experience
James Van Horne, MD, Alaine Van Horne, BS, Nick Liao, MS, Victoria Romo-LeTourneau, PharmD
James Van Horne, MD; Alaine Van Horne, BS; Nick Liao, MS; Victoria Romo-LeTourneau, PharmD
Read More
Original Research, Practice Management, Pain
Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019
Mohammed M. Alsultan, PharmD, PhD, Jeff Jianfei Guo, BPharm, PhD
Mohammed M. Alsultan, PharmD, PhD; Jeff Jianfei Guo, BPharm, PhD
Read More
Page 16 of 244
Results 151 - 160 of 2434